TrialWorld journal of urology2021

Efficacy and safety of mirabegron versus solifenacin as additional therapy for persistent OAB symptoms after tamsulosin monotherapy in men with probable BPO.

Mohamed G Soliman et al.PubMed ↗Publisher ↗

No numbers read from the abstract.